SCHEMBL6884062

SCHEMBL6884062

O=C1c2ccc(Br)cc2C(=O)c2ccc(Cl)cc21

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 3/20 0.62
▸ MCL1 Q07820 2/20 0.62
▸ S100A4 P26447 3/20 0.61
▸ PTPRC P08575 1/20 0.59
▸ HSP90AA1 P07900 1/20 0.52
▸ PPOX P50336 1/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ ESR1 P03372 1/20 0.45
▸ MAOA P21397 1/20 0.45
▸ UGT1A1 P22309 1/20 0.45
▸ MAOB P27338 1/20 0.45
▸ ESR2 Q92731 1/20 0.45
▸ LCK P06239 1/20 0.44
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ CA4 P22748 1/20 0.42
▸ CA7 P43166 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ ITGA1 P56199 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29914626 0.96 S100A4 (0.63) BCL2MCL1S100A4PTPRCHSP90AA1
SCHEMBL23294517 0.96 S100A4 (0.63) BCL2MCL1S100A4PTPRCHSP90AA1
SCHEMBL24730389 0.96 BCL2 (0.57) BCL2MCL1S100A4PTPRCHSP90AA1
SCHEMBL29018327 0.93 S100A4 (0.72) BCL2MCL1S100A4PTPRCHSP90AA1
SCHEMBL1758285 0.92 S100A4 (0.61) BCL2MCL1S100A4PTPRCHSP90AA1
SCHEMBL762135 0.87 S100A4 (0.80) BCL2MCL1S100A4PTPRCNPC1
SCHEMBL4229683 0.87 S100A4 (0.80) BCL2MCL1S100A4HSP90AA1PPOX
SCHEMBL353693 0.87 S100A4 (0.80) BCL2MCL1S100A4HSP90AA1PPOX
SCHEMBL29664078 0.87 S100A4 (0.80) BCL2MCL1S100A4PTPRCNPC1
SCHEMBL3717374 0.87 S100A4 (0.80) BCL2MCL1S100A4PTPRCNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183200-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME SFC CO., LTD (KR) 2023-06-15 — — US disclosed
US-20230183200-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME SFC CO., LTD (KR) 2023-06-15 — — US disclosed
US-6723870-B2 REACTING A METAL HYDRIDE WITH AN ANTHRAQUINONE, DEKETALIZATION; DYE INTERMEDIATES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-04-20 — — US disclosed
US-20030069443-A1 Method for producing anthracenes SUMITOMO CHEMICAL COMPANY, LIMITED 2003-04-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183200-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME TRPA1, CRY2, SUN2 BCL2 2745/4885MCL1 1998/4885S100A4 2674/4885
US-20030069443-A1 Method for producing anthracenes AKR7A2, ADH1A, CYP2E1 BCL2 2265/4885MCL1 479/4885S100A4 1489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback